Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2023-08-13 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Disclosure of subsisting Shareholders Agreement - Exercise of common voting rights
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to the stock exchange (BSE Limited) regarding the disclosure of a subsisting Shareholders Agreement among the shareholders of the erstwhile promoter entity, DVK Investments Private Limited, following a merger with Fermenta Biotech Limited. It references compliance with SEBI Listing Obligations and Disclosure Requirements (Regulation 30 and 30A), which pertain to continuous disclosure obligations for listed companies. The content focuses on the disclosure of a shareholders agreement and related voting rights, not on financial results, management changes, or other report types. It is a regulatory announcement informing the exchange and public about a material event related to shareholding and governance but does not constitute a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-13 English
Company''s factory at Kullu, Himachal Pradesh, has now been restored to normalcy since August 11, 2023.
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to a stock exchange (BSE Limited) regarding the restoration of normalcy at the company's factory after a natural calamity. It references compliance with SEBI regulations and a specific SEBI circular. The content includes details about the damage, insurance claims, and steps taken to restore operations. The document is an update or announcement about an operational event affecting the company, not a financial report, earnings release, or management discussion. It is relatively short (2588 characters) and serves as a regulatory disclosure under SEBI Listing Obligations. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-11 English
The Board has approved the unaudited financial results for quarter ended June 30, 2023 along with limited review reports thereon
Regulatory Filings
2023-08-11 English
We write to inform you that the Board of Directors of the Company at its meeting held on August 11, 2023 has, inter alia, approved / recommended the following: (1) Unaudited Financial ....
Regulatory Filings
2023-08-11 English
Pursuant to Reg 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we inform you that the Company has received information from shareholders about the ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) regarding the loss of share certificates by a shareholder. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the intimation of loss of share certificates. The content is about notifying the exchange of this event for record purposes. There is no financial data, no report attached or referenced as being published, no management discussion, no earnings information, no voting results, or any other report type. This is a regulatory compliance notification related to share certificate loss, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-08-09 English
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Regulatory Filings Classification · 95% confidence The document is a notice from the company to the stock exchange about the scheduling of a Board Meeting to consider and approve unaudited financial results for the quarter ended June 30, 2023. It also mentions the closure of the trading window in compliance with insider trading regulations. The document is short (2163 characters) and serves as an announcement of an upcoming event and regulatory compliance, not the financial results themselves. It does not contain any financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-08-02 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.